RhumbLine Advisers’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768K | Buy |
221,853
+47,728
| +27% | +$165K | ﹤0.01% | 2382 |
|
|
2025
Q1 | $456K | Buy |
174,125
+2,681
| +2% | +$7.02K | ﹤0.01% | 2636 |
|
|
2024
Q4 | $706K | Buy |
171,444
+13,532
| +9% | +$55.8K | ﹤0.01% | 2445 |
|
|
2024
Q3 | $1.12M | Sell |
157,912
-5,983
| -4% | -$42.4K | ﹤0.01% | 2207 |
|
|
2024
Q2 | $1.07M | Buy |
163,895
+7,508
| +5% | +$49K | ﹤0.01% | 2204 |
|
|
2024
Q1 | $1.3M | Buy |
156,387
+4,942
| +3% | +$41K | ﹤0.01% | 2113 |
|
|
2023
Q4 | $1.67M | Sell |
151,445
-1,732
| -1% | -$19.1K | ﹤0.01% | 2002 |
|
|
2023
Q3 | $1.29M | Buy |
153,177
+4,771
| +3% | +$40.1K | ﹤0.01% | 2070 |
|
|
2023
Q2 | $1.86M | Buy |
148,406
+12,846
| +9% | +$161K | ﹤0.01% | 1945 |
|
|
2023
Q1 | $2.23M | Buy |
135,560
+6,696
| +5% | +$110K | ﹤0.01% | 1745 |
|
|
2022
Q4 | $1.93M | Buy |
128,864
+10,305
| +9% | +$154K | ﹤0.01% | 1805 |
|
|
2022
Q3 | $2.65M | Buy |
118,559
+8,122
| +7% | +$182K | ﹤0.01% | 1617 |
|
|
2022
Q2 | $1.85M | Buy |
110,437
+34,999
| +46% | +$586K | ﹤0.01% | 1800 |
|
|
2022
Q1 | $2.26M | Buy |
75,438
+5,437
| +8% | +$163K | ﹤0.01% | 1752 |
|
|
2021
Q4 | $2.15M | Buy |
70,001
+8,260
| +13% | +$254K | ﹤0.01% | 1839 |
|
|
2021
Q3 | $1.95M | Buy |
61,741
+2,876
| +5% | +$90.7K | ﹤0.01% | 1922 |
|
|
2021
Q2 | $2.15M | Buy |
58,865
+8,583
| +17% | +$314K | ﹤0.01% | 1916 |
|
|
2021
Q1 | $1.74M | Buy |
50,282
+9,902
| +25% | +$342K | ﹤0.01% | 1973 |
|
|
2020
Q4 | $1.68M | Buy |
40,380
+3,771
| +10% | +$157K | ﹤0.01% | 1931 |
|
|
2020
Q3 | $1.56M | Buy |
+36,609
| New | +$1.56M | ﹤0.01% | 1808 |
|